J 2020

Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells

GIALLONGO, Sebastiano, M. DI ROSA, R. CALTABIANO, L. LONGHITANO, M. REIBALDI et. al.

Basic information

Original name

Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells

Authors

GIALLONGO, Sebastiano (380 Italy, belonging to the institution), M. DI ROSA (380 Italy), R. CALTABIANO (380 Italy), L. LONGHITANO (380 Italy), M. REIBALDI (380 Italy), A. DISTEFANO (380 Italy), Oriana LO RE (380 Italy, belonging to the institution), A. M. AMORINI (380 Italy), L. PUZZO (380 Italy), L. SALVATORELLI (380 Italy), S. PALMUCCI (380 Italy), D. TIBULLO (380 Italy), A. RUSSO (380 Italy), A. LONGO (380 Italy), G. LAZZARINO (380 Italy), G. LI VOLTI (380 Italy) and Manlio VINCIGUERRA (380 Italy, guarantor)

Edition

AGING-US, ORCHARD PARK, IMPACT JOURNALS LLC, 2020, 1945-4589

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.682

RIV identification code

RIV/00216224:14110/20:00116011

Organization unit

Faculty of Medicine

UT WoS

000537718700058

Keywords in English

macroH2A1; histones; uveal melanoma; metabolism; epigenetics

Tags

Tags

International impact, Reviewed
Změněno: 16/7/2020 12:49, Mgr. Tereza Miškechová

Abstract

V originále

Uveal melanoma (UM) is the most common primary intraocular tumour in adults. The most accurate prognostic factor of UM is classification by gene expression profiling. Currently, the role of epigenetics is much less defined compared to genetic mechanisms. We recently showed a strong prognostic role of the expression levels of histone variant macroH2A1 in UM patients. Here, we assessed the mechanistic effects of macroH2A1 on UM progression. UM cell lines were stably knocked down (KD) for macroH2A1, and proliferation and colony formation capacity were evaluated. Mitochondrial function was assayed through qPCR and HPLC analyses. Correlation between mitochondrial gene expression and cancer aggressiveness was studied using a bioinformatics approach. MacroH2A1 loss significantly attenuated UM cells proliferation and aggressiveness. Furthermore, genes involved in oxidative phosphorylation displayed a decreased expression in KD cells. Consistently, macroH2A1 loss resulted also in a significant decrease of mitochondrial transcription factor A (TFAM) expression, suggesting impaired mitochondrial replication. Bioinformatics analyses uncovered that the expression of genes involved in mitochondrial metabolism correlates with macroH2A1 and with cancer aggressiveness in UM patients. Altogether, our results suggest that macroH2A1 controls UM cells progression and it may represent a molecular target to develop new pharmacological strategies for UM treatment.